Sign in to view content

Phase 3 Randomized, Double-Masked Studies of Brolucizumab Versus Aflibercept in nAMD: Expanded Primary and Secondary Outcomes From HAWK/HARRIER

Arshad M. Khanani, MD

Video
Published 2018

Related

Brolucizumab in HAWK/HARRIER: Outcomes, Efficacy, & Dosing Status – Everything You Need to Know!
David M. Brown, MD
Updates from the Field
2018
Endophthalmitis Rates of Prefilled Ranibizumab Syringes Compared to Conventional Ranibizumab Vials: An International Multicenter Study
Yoshihiro Yonekawa, MD
Annual Meeting Talks
2018
Orbital Emphysema as a Complication of Vitrectomy: Report of 12 Consecutive Cases
Virgilio Morales-Canton, MD
Annual Meeting Talks
2018

Category: Age-Related Macular Degeneration

See more